Submission Details
| 510(k) Number | K250079 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 13, 2025 |
| Decision Date | March 14, 2025 |
| Days to Decision | 60 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
K250079 is an FDA 510(k) clearance for the Ruby XL System, a Device, Vascular, For Promoting Embolization (Class II — Special Controls, product code KRD), submitted by Penumbra, Inc. (Alameda, US). The FDA issued a Cleared decision on March 14, 2025, 60 days after receiving the submission on January 13, 2025. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.3300.
| 510(k) Number | K250079 FDA.gov |
| FDA Decision | Cleared SESE |
| Date Received | January 13, 2025 |
| Decision Date | March 14, 2025 |
| Days to Decision | 60 days |
| Submission Type | Traditional |
| Review Panel | Cardiovascular (CV) |
| Summary | Summary PDF |
| Product Code | KRD — Device, Vascular, For Promoting Embolization |
| Device Class | Class II — Special Controls |
| CFR Regulation | 21 CFR 870.3300 |